Trumenba
Payments companies reported to CMS as associated with Trumenba. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trumenba, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trumenba
These are the largest totals companies reported as associated with Trumenba. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaime Fergie | Corpus Christi, TX | Pediatric Infectious Diseases | $12,517.19 |
| Jana Shaw | Watertown, NY | Pediatric Infectious Diseases | $11,913.48 |
| Richard Chung | Philadelphia, PA | Adolescent Medicine (Pediatrics) | $10,719.00 |
| Stephanie Hanenberg | Colorado Springs, CO | Family | $10,456.91 |
| Julio Ramirez | Louisville, KY | Infectious Disease | $7,400.00 |
| Gary Marshall | Louisville, KY | Pediatric Infectious Diseases | $7,184.73 |
| Archana Chatterjee | Sioux Falls, SD | Pediatric Infectious Diseases | $3,995.11 |
| Tamera Coyne-Beasley | Birmingham, AL | Pediatrics | $3,843.39 |
| Ruth Carrico | Chicago, IL | Family | $2,250.00 |
| Boris Skurkovich | Providence, RI | Pediatrics | $1,500.00 |
Prescribed Trumenba?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.